Evidence dossier · candidate cand-covid-bell-s-palsy · CICP program · · DRAFT — not a determination
This is a draft research-tracking dossier, not a determination that COVID-19 vaccine causes Bell's Palsy, and not an incidence or legal finding. All evidence is flagged needs_human_review and must be reviewed before any page is published or cited. Every value is grounded in retrieved citations (PMID + retrieval date); unsourced items read "no evidence found / not assessable". Symmetric search: every supporting query has a mirror/null query, and zeros are shown (negative dossiers report the absence of signal).
Claim matrix (C1–C6, computed)
Claim
Label
Status
Missing nodes
C1
Coherent clinical object exists
supported
C2
Consistent temporal window
supported
C3
Epidemiologic excess risk
insufficient_data
missing: B1 B3
C4
Consistency / replication
contested
C5
Specificity (product / dose)
contested
C6
Biological mechanism
insufficient_data
missing: E1
Two evidentiary bars apply to the epi nodes/claims (C3, C4): · VICP — preponderance of the evidence. · CICP (off-Table) — compelling, reliable, valid medical and scientific evidence (higher bar).
Bradford Hill assessment (computed)
Each viewpoint is derived from the node statuses below (see the framework crosswalk in compensation-tables-schema.md §8). Hill's viewpoints are aids to judgement, not a scoring checklist that proves causation; temporality is the only strictly necessary criterion.
Viewpoint
What it asks
Status (from evidence)
Temporality(necessary)
cause precedes effect in a plausible window (necessary)
NASEM (formerly IOM), "Adverse Effects of Vaccines: Evidence and Causality" (2011, updated 2024). Independent grading of epidemiologic and mechanistic evidence, synthesized into one of four causal-conclusion categories. This is a computed approximation of that framework, not a NASEM determination. See compensation-tables-schema.md §8bis.
Case-definition standard: no established case definition (needs_human_review — not in spec §1's named-standard list) — governs the case-certainty scale on A1/A2/A6/A8 below. See compensation-tables-schema.md §8ter.
Evidence matrix (68 nodes by workstream)
68 of 68 nodes evaluated · 136 PubMed queries logged (supporting + mirror, incl. zeros). Statuses are computed from retrieved citations; not hand-set.
Definition & attribution 24/24 evaluated
A1 · Case reportssupports
Measure: New definite object in risk window T Comparator: Pre-vaccination baseline Hit rule: Definite object present, onset in window, competing causes considered
Finding: Several case reports describe new-onset Bell's palsy within hours to weeks after administration of mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna), with onset in a plausible risk window and after competing causes were considered, though a systematic review notes Bell's palsy is a rare adverse event.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Case reports pubmed · 66197 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
ambiguous 37927346 · EXCLI journal (2023) — Bell's palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature.
ambiguous 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
A2 · Series with objective confirmationsupports
Measure: Definite object plus objective test Comparator: Reference range / diagnostic criteria Hit rule: Objective confirmation in >=1 case per the working definition
Finding: Three case reports and a systematic review describe instances of Bell's palsy occurring shortly after COVID-19 vaccination, with objective neurological findings and exclusion of other causes, but evidence is limited to individual cases and a review without quantitative synthesis.
Measure: Distribution of onset times after dose Comparator: Pre-specified risk window Hit rule: Onset clusters inside the pre-specified window (not uniform/flat)
Finding: Retrieved case reports describe Bell's palsy onset occurring within hours to weeks after COVID-19 vaccination, including onset at less than 3 hours, 2 weeks, and 10 days post-dose, suggesting clustering within a pre-specified risk window rather than a uniform distribution.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Onset histogram pubmed · 29 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
17 retrieved record(s)
supports_node 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
ambiguous 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
ambiguous 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
supports_node 37198509 · Acta neurologica Taiwanica (2023) — A case with prolonged headache after COVID-19 vaccination and later developed Bell's palsy.
ambiguous 34330676 · Neurologia (2021) — Bell's palsy following COVID-19 vaccination: a case report.
A4 · Temporal plausibilitysupports
Measure: Onset latency vs object pathophysiology Comparator: Object's known natural latency Hit rule: Onset latency consistent with the object's pathophysiology
Finding: Multiple case reports and a systematic review document Bell's palsy onset hours to weeks after COVID-19 vaccination, with onset latencies as short as 3 hours, 2 weeks, and 10 days post-vaccination, consistent with a temporal plausibility for vaccine-related pathophysiology.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Temporal plausibility pubmed · 58 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
ambiguous 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
ambiguous 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
ambiguous 37198509 · Acta neurologica Taiwanica (2023) — A case with prolonged headache after COVID-19 vaccination and later developed Bell's palsy.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
A5 · Onset-interval documentationno_data
Measure: Onset interval documented in source Comparator: Dose date Hit rule: Onset interval is recorded (not imputed) in a primary source
Finding: Multiple case reports describe Bell's palsy onset after COVID-19 vaccination, with some explicitly recording the onset interval (e.g., within 3 hours, 2 weeks post-second dose), but the retrieved evidence consists entirely of case reports and systematic reviews of case reports, not primary epidemiological studies that systematically document onset intervals for a defined case series.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Onset-interval documentation pubmed · 27 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
supports_node 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
ambiguous 34330676 · Neurologia (2021) — Bell's palsy following COVID-19 vaccination: a case report.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
A6 · Differential diagnosis excludedmixed
Measure: Competing causes assessed and excluded Comparator: Likely alternative diagnoses Hit rule: Pre-specified competing causes ruled out per the working definition
Finding: Two systematic reviews and one case report indicate that Bell's palsy following COVID-19 vaccination has been reported, and in the case report, competing causes were assessed and excluded, but the evidence specifically addressing systematic exclusion of competing causes for the node is limited.
does_not_resolve 36381561 · Public health in practice (Oxford, Engla (2022) — Monkeypox vaccine-related stigma.
A7 · Rechallenge / re-exposureno_data
Measure: Object recurs on a further dose Comparator: First-dose response Hit rule: Object recurs after a subsequent dose (re-exposure)
Finding: The retrieved evidence includes case reports of Bell's palsy occurring after a second dose of COVID-19 vaccine (e.g., after the second dose of Moderna vaccine [PMID 35474926], and after a subsequent dose in a patient who received both the first and second dose [PMID 35075436 describes a case following vaccination but does not specify re-exposure]), but no case explicitly documents a recurrence of Bell's palsy upon re-exposure (i.e., a new episode after a further dose following an initial episode).
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Rechallenge / re-exposure pubmed · 29 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
ambiguous 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 34336436 · Cureus (2021) — Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
A8 · Adjudicated by criteria (no established case definition)no_data
Measure: Object adjudicated by published criteria Comparator: Published clinical / Brighton criteria Hit rule: Cases adjudicated to 'definite' by a published criterion set
Finding: The retrieved evidence consists solely of case reports and a systematic review describing individual instances of Bell's palsy following COVID-19 vaccination, with no application of published adjudication criteria to classify cases as 'definite'.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Adjudicated by criteria pubmed · 66 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
ambiguous 35474926 · Acta medica Lituanica (2021) — Bell's Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
ambiguous 34330676 · Neurologia (2021) — Bell's palsy following COVID-19 vaccination: a case report.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
A9 · Natural-history consistencysupports
Measure: Course matches the object's natural history Comparator: Known natural history of the object Hit rule: Clinical course (onset, peak, recovery) matches the object's natural history
Finding: The retrieved evidence consists of case reports and a systematic review describing instances of Bell's palsy occurring shortly after COVID-19 vaccination, typically with acute onset, unilateral facial paralysis, and transient or self-limited recovery, which is consistent with the known natural history of idiopathic Bell's palsy.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series Natural-history consistency pubmed · 130 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
13 retrieved record(s)
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
does_not_resolve 37775180 · Clinical medicine (London, England) (2023) — SARS-CoV-2 vaccines and myocarditis.
does_not_resolve 36441403 · Current cardiology reports (2022) — COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation.
ambiguous 30000765 · (2006) — Human Papillomavirus Vaccines.
A10 · No confounding objectmixed
Measure: Not attributable to a co-occurring condition Comparator: Co-occurring illness that could produce the object Hit rule: Object not better explained by a co-occurring condition (infection, etc.)
Finding: Several case reports and a systematic review describe Bell's palsy following COVID-19 vaccination, with some reports noting that competing causes were assessed and found negative, but the evidence consists primarily of case reports and uncontrolled observations, not controlled epidemiological studies.
supporting: COVID-19 vaccine Bell's Palsy case report OR case series No confounding object pubmed · 46 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy alternative diagnosis OR not vaccine-related pubmed · 4055 hits · run 2026-09-07
16 retrieved record(s)
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
supports_node 37167495 · The National medical journal of India (2022) — Transient Bell's palsy following Covid-19 vaccination.
supports_node 35663122 · Annals of medicine and surgery (2012) (2022) — Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
ambiguous 34336436 · Cureus (2021) — Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
supports_node 35910698 · Cureus (2022) — Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination.
ambiguous 33647971 · QJM : monthly journal of the Association (2021) — COVID-19 vaccine-related myositis.
D1 · Predicted site of injuryno_data
Measure: Object at the site the mechanism predicts Comparator: Predicted anatomic site from the mechanism Hit rule: Object localizes to the anatomic site the mechanism predicts
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy anatomic localization Predicted site of injury mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Predicted site of injury not consistent with mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
D2 · Spared structuresno_data
Measure: Structures the mechanism should spare are spared Comparator: Structures predicted unaffected Hit rule: Structures predicted spared by the mechanism are indeed spared
mirror: COVID-19 vaccine Bell's Palsy Spared structures not consistent with mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
D3 · Local vs systemic distributionno_data
Measure: Distribution matches mechanism scope Comparator: Local (injection site) vs systemic expectation Hit rule: Observed distribution (local vs systemic) matches the mechanism's predicted scope
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy anatomic localization Local vs systemic distribution mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Local vs systemic distribution not consistent with mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
D4 · Kinetics classno_data
Measure: Onset/offset kinetics match the mechanism Comparator: Expected kinetic class (acute vs chronic) Hit rule: Onset and offset kinetics are in the class the mechanism predicts
mirror: COVID-19 vaccine Bell's Palsy Kinetics class not consistent with mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
D5 · Platform-mechanism matchno_data
Measure: Mechanism is consistent with the platform Comparator: Mechanistic expectation for the platform Hit rule: The proposed mechanism is biologically consistent with the vaccine platform
mirror: COVID-19 vaccine Bell's Palsy Platform-mechanism match not consistent with mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
H3 · Targeted treatment reversesno_data
Measure: A targeted treatment reverses the object in patients Comparator: Treatment-naive / placebo Hit rule: A mechanism-directed treatment reverses the object (vs control treatment)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Targeted treatment reverses intervention OR treatment OR reversal pubmed · 15142392 hits · run 2026-09-07
Measure: No node's finding contradicts another Comparator: Internal consistency across nodes Hit rule: No evaluated node directly contradicts another (coherence)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy No internal contradiction coherence OR latency OR susceptibility pubmed · 870068 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy No internal contradiction inconsistent OR contradicts pubmed · 27612 hits · run 2026-09-07
I2 · Analogy to a known objectno_data
Measure: Object analogous to a well-established analog Comparator: Established analog's profile Hit rule: The object's profile matches a well-established analog on key features
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Analogy to a known object coherence OR latency OR susceptibility pubmed · 870068 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Analogy to a known object inconsistent OR contradicts pubmed · 27612 hits · run 2026-09-07
I5 · Latency coherenceno_data
Measure: Observed latency matches the mechanism's latency Comparator: Mechanism-predicted latency Hit rule: Observed onset latency is coherent with the mechanism's predicted latency
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Latency coherence coherence OR latency OR susceptibility pubmed · 870068 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Latency coherence inconsistent OR contradicts pubmed · 27612 hits · run 2026-09-07
J1 · Pre-specificationno_data
Measure: Window/hit-rule pre-specified before data Comparator: Pre-specified vs post-hoc Hit rule: The risk window, object, and hit rule were pre-specified before data were seen
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Pre-specification pre-specified OR adjudicated pubmed · 13550 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Pre-specification post-hoc OR hypothesis-generating only pubmed · 1700 hits · run 2026-09-07
3 retrieved record(s)
does_not_resolve 39226489 · Journal of clinical oncology : official (2024) — Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease
does_not_resolve 41493293 · Journal of the American College of Cardi (2026) — Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
does_not_resolve 35412949 · Human vaccines & immunotherapeutics (2022) — Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach.
J2 · Contrary-evidence logno_data
Measure: Contrary evidence is logged, not omitted Comparator: Support-only dossier Hit rule: Contrary / null / refuting findings are logged and shown alongside support
Finding: No evidence found directly addressing Bell's Palsy as a contrary/null/refuting finding for COVID-19 vaccine attribution in the retrieved evidence.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Contrary-evidence log pre-specified OR adjudicated pubmed · 13550 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Contrary-evidence log post-hoc OR hypothesis-generating only pubmed · 1700 hits · run 2026-09-07
3 retrieved record(s)
does_not_resolve 39226489 · Journal of clinical oncology : official (2024) — Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease
does_not_resolve 41493293 · Journal of the American College of Cardi (2026) — Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
does_not_resolve 35412949 · Human vaccines & immunotherapeutics (2022) — Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach.
J3 · No temporality-only claimno_data
Measure: Claim not based on temporality alone Comparator: Sequence-only evidence Hit rule: The claim is not supported by temporal sequence alone (independent evidence exists)
Finding: The retrieved evidence does not address Bell's Palsy following COVID-19 vaccination; PMID 39226489 and PMID 41493293 concern immune-related adverse events from immune checkpoint inhibitors and AI adjudication of cardiovascular events, respectively, while PMID 35412949 discusses immune thrombotic thrombocytopenia after specific COVID-19 vaccines but not Bell's Palsy.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy No temporality-only claim pre-specified OR adjudicated pubmed · 13551 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy No temporality-only claim post-hoc OR hypothesis-generating only pubmed · 1701 hits · run 2026-09-07
3 retrieved record(s)
does_not_resolve 39226489 · Journal of clinical oncology : official (2024) — Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease
does_not_resolve 41493293 · Journal of the American College of Cardi (2026) — Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
does_not_resolve 35412949 · Human vaccines & immunotherapeutics (2022) — Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach.
J4 · Passive-surveillance roleno_data
Measure: Passive-surveillance findings bounded correctly Comparator: Active-surveillance confirmation Hit rule: Passive-surveillance signals are framed as hypothesis-generating, not confirmatory
Finding: The retrieved evidence does not mention Bell's Palsy, COVID-19 vaccine, or passive surveillance; it focuses on immune-related adverse events from immune checkpoint inhibitors and on AI-based adjudication of cardiovascular events in clinical trials.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Passive-surveillance role pre-specified OR adjudicated pubmed · 13550 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Passive-surveillance role post-hoc OR hypothesis-generating only pubmed · 1700 hits · run 2026-09-07
3 retrieved record(s)
does_not_resolve 39226489 · Journal of clinical oncology : official (2024) — Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease
does_not_resolve 41493293 · Journal of the American College of Cardi (2026) — Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
does_not_resolve 35412949 · Human vaccines & immunotherapeutics (2022) — Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach.
J5 · Dose mappingno_data
Measure: Dose/lot exposure mapped to the object Comparator: Unmapped exposure Hit rule: Dose / lot exposure is mapped to the object where the mechanism predicts it
Finding: The retrieved evidence does not address Bell's palsy after COVID-19 vaccination: one study focuses on immune checkpoint inhibitor-related adverse events, and the other discusses vaccine-induced immune thrombotic thrombocytopenia, neither of which is directly relevant to the node definition for Bell's palsy.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Dose mapping pre-specified OR adjudicated pubmed · 13550 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Dose mapping post-hoc OR hypothesis-generating only pubmed · 1700 hits · run 2026-09-07
2 retrieved record(s)
does_not_resolve 39226489 · Journal of clinical oncology : official (2024) — Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease
does_not_resolve 35412949 · Human vaccines & immunotherapeutics (2022) — Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach.
Epidemiologic chassis 13/13 evaluated
B1 · Excess vs baselineno_data
Measure: RR/IRR vs unexposed or prior window Comparator: Unvaccinated person-time or pre-vaccination window Hit rule: RR/IRR > 1 with CI excluding 1 after pre-specified confounders
Finding: PMID 40664645 includes Bell's palsy as one of 15 adverse events assessed after XBB.1.5-containing COVID-19 mRNA vaccination, but the abstract provides no specific estimate for Bell's palsy; the other retrieved PMIDs do not address Bell's palsy after COVID-19 vaccination.
supporting: COVID-19 vaccine Bell's Palsy Excess vs baseline incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Excess vs baseline pubmed · 88553 hits · run 2026-09-07
9 retrieved record(s)
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40664645 · Nature communications (2025) — Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
does_not_resolve 38388239 · Vaccine (2024) — Mortality risk after COVID-19 vaccination: A self-controlled case series study.
does_not_resolve 34937500 · Expert review of vaccines (2022) — Self-controlled case series design in vaccine safety: a systematic review.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
does_not_resolve 34489307 · Gut (2022) — Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
B2 · SCCSno_data
Measure: Self-controlled case series risk ratio Comparator: Individuals' own risk intervals (no-event) Hit rule: SCCS risk ratio > 1 in the post-vaccination window, CI excluding 1
Finding: The retrieved evidence includes one SCCS study (PMID 40664645) that explicitly assessed Bell's palsy as an adverse event following XBB.1.5-containing COVID-19 mRNA vaccines, but the abstract does not report a risk ratio or confidence interval for Bell's palsy specifically. Other retrieved SCCS studies address mortality, Guillain-Barré syndrome, myasthenia gravis, arrhythmias, retinal vein occlusion, tinnitus, or general safety surveillance, none of which provide a risk ratio for Bell's palsy with a CI excluding 1. Several case reports and systematic reviews (e.g., PMID 36128311, 36288776, 37167495) describe Bell's palsy after COVID-19 vaccination but do not meet the SCCS risk-ratio evidence standard required for this node.
supporting: COVID-19 vaccine Bell's Palsy SCCS incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk SCCS pubmed · 88659 hits · run 2026-09-07
12 retrieved record(s)
does_not_resolve 38388239 · Vaccine (2024) — Mortality risk after COVID-19 vaccination: A self-controlled case series study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 37223097 · Frontiers in immunology (2023) — Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.
refutes_node 40664645 · Nature communications (2025) — Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 36813998 · Eye (London, England) (2023) — Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series.
does_not_resolve 40716143 · Vaccine (2025) — Tinnitus risk after COVID-19 XBB.1.5 vaccination: A self-controlled case series study.
refutes_node 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
B3 · Cohort / risk-intervalno_data
Measure: Incidence rate ratio in defined window Comparator: Pre-specified risk vs comparison interval Hit rule: IRR > 1 in the pre-specified window, CI excluding 1, stratified by age/sex
Finding: No retrieved evidence directly addresses the risk of Bell's palsy following COVID-19 vaccination using a cohort design with an incidence rate ratio in a pre-specified risk window, stratified by age and sex.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Cohort / risk-interval incidence risk cohort OR self-controlled case series pubmed · 946 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Cohort / risk-interval pubmed · 88161 hits · run 2026-09-07
9 retrieved record(s)
does_not_resolve 38388239 · Vaccine (2024) — Mortality risk after COVID-19 vaccination: A self-controlled case series study.
does_not_resolve 28467420 · PloS one (2017) — Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 36813998 · Eye (London, England) (2023) — Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series.
does_not_resolve 37223097 · Frontiers in immunology (2023) — Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.
does_not_resolve 34937500 · Expert review of vaccines (2022) — Self-controlled case series design in vaccine safety: a systematic review.
ambiguous 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
B4 · Meta-analysis / poolingno_data
Measure: Pooled effect across studies Comparator: Pooled estimate with heterogeneity Hit rule: Pooled estimate > 1 (or < 1) with quantified heterogeneity (I2)
Finding: A single systematic review and meta-analysis (PMID 37272720) directly addresses the association between COVID-19 vaccination and Bell's Palsy, reporting pooled odds ratios comparing incidence in vaccinated versus unvaccinated groups, with quantified heterogeneity; however, the retrieved evidence does not provide the specific pooled estimate or I² value needed to assess the hit rule (pooled estimate > 1 with quantified heterogeneity).
supporting: COVID-19 vaccine Bell's Palsy Meta-analysis / pooling incidence risk cohort OR self-controlled case series pubmed · 946 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Meta-analysis / pooling pubmed · 111997 hits · run 2026-09-07
11 retrieved record(s)
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 34937500 · Expert review of vaccines (2022) — Self-controlled case series design in vaccine safety: a systematic review.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
does_not_resolve 29402646 · Journal of the American Medical Director (2018) — Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: III. Others.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
ambiguous 36143376 · Life (Basel, Switzerland) (2022) — Safety of COVID-19 Vaccines: Spotlight on Neurological Complications.
B5 · Negative-control outcomesno_data
Measure: No excess for outcomes the vaccine should not cause Comparator: Negative-control outcomes (unaffected by mechanism) Hit rule: Null for negative-control outcomes while target outcome is positive (specificity)
Finding: No retrieved evidence directly addresses Bell's palsy after COVID-19 vaccination as a negative-control outcome; the only relevant study (PMID 37272720) is a meta-analysis on Bell's palsy incidence but was not retrieved as a primary source for this node and does not address the negative-control framework.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Negative-control outcomes incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Negative-control outcomes pubmed · 88364 hits · run 2026-09-07
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
B6 · Other-antigen comparisonno_data
Measure: Risk vs a different-antigen comparator Comparator: Comparator product with a different antigen Hit rule: Risk specific to the target antigen, not shared with the comparator antigen
Finding: No retrieved evidence directly compares the risk of Bell's palsy following COVID-19 vaccination to the risk following a different-antigen comparator. The retrieved studies focus on shingles after RZV, arrhythmias after COVID-19, Guillain-Barré after COVID-19 vaccination or infection, and various vaccine safety methods or reviews; the three systematic reviews on Bell's palsy and COVID-19 vaccines (PMID 37272720, 36128311, 36038397) and the case report (PMID 37167495) lack a different-antigen comparator, and the other citations are not relevant to this node.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Other-antigen comparison incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Other-antigen comparison pubmed · 88126 hits · run 2026-09-07
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 34937500 · Expert review of vaccines (2022) — Self-controlled case series design in vaccine safety: a systematic review.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
ambiguous 36143376 · Life (Basel, Switzerland) (2022) — Safety of COVID-19 Vaccines: Spotlight on Neurological Complications.
B7 · Absolute riskno_data
Measure: Per-100k risk in window Comparator: Absolute incidence per 100k Hit rule: Absolute risk reported and stable across the window (not an artifact of rarity)
Finding: One retrieved study (PMID 40664645) assessed Bell's palsy as an adverse event following XBB.1.5-containing COVID-19 mRNA vaccines but did not report absolute risk per 100,000 or a stable risk-window estimate. A systematic review (PMID 36128311) reported Bell's palsy as a rare adverse event following COVID-19 vaccination but provided no per-100k absolute risk estimate for a defined risk window.
does_not_resolve 38388239 · Vaccine (2024) — Mortality risk after COVID-19 vaccination: A self-controlled case series study.
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 37223097 · Frontiers in immunology (2023) — Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.
refutes_node 40664645 · Nature communications (2025) — Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
does_not_resolve 29211679 · The New England journal of medicine (2017) — Contemporary Hormonal Contraception and the Risk of Breast Cancer.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
B8 · Platform splitno_data
Measure: Risk by vaccine platform / product Comparator: Platform (mRNA vs viral vector, etc.) Hit rule: Risk attributable to a specific platform, not to 'a vaccine' generally
Finding: The retrieved evidence includes a systematic review (PMID 36128311) and a narrative review (PMID 36038397) tracking cases of Bell's palsy after COVID-19 vaccination, but no retrieved study provides a platform-specific attributable risk estimate or compares risk across vaccine platforms as required by the hit rule for this node.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Platform split incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Platform split pubmed · 88191 hits · run 2026-09-07
11 retrieved record(s)
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
refutes_node 40664645 · Nature communications (2025) — Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
does_not_resolve 37806668 · Human vaccines & immunotherapeutics (2023) — Response to Dr. Somovilla del Saz's letter to the editor regarding "Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-a
does_not_resolve 37534766 · Human vaccines & immunotherapeutics (2023) — Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies.
refutes_node 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
ambiguous 36128311 · Medical journal of the Islamic Republic (2022) — Bell's Palsy and COVID-19 Vaccination: A Systematic Review.
B9 · Host-structure stratificationno_data
Measure: Risk by age / sex / host structure Comparator: Unstratified estimate Hit rule: Risk concentrated in a defined host subgroup (e.g. young males), stable across sources
Finding: The retrieved evidence includes a self-controlled case series study evaluating Bell's palsy after XBB.1.5-containing COVID-19 mRNA vaccines (PMID 40664645), but it does not provide results stratified by host subgroups such as age or sex for this outcome; other retrieved articles are reviews or case reports (e.g., PMID 36128311, 37167495) that do not present stable, stratified risk estimates across sources.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Host-structure stratification incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Host-structure stratification pubmed · 88124 hits · run 2026-09-07
12 retrieved record(s)
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
refutes_node 40664645 · Nature communications (2025) — Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
does_not_resolve 37806668 · Human vaccines & immunotherapeutics (2023) — Response to Dr. Somovilla del Saz's letter to the editor regarding "Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-a
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
does_not_resolve 36143376 · Life (Basel, Switzerland) (2022) — Safety of COVID-19 Vaccines: Spotlight on Neurological Complications.
Measure: Risk tracks a formulation change Comparator: Pre- vs post-change formulation Hit rule: Risk change tracks a documented formulation / component change over time
Finding: No retrieved evidence directly addresses the association between COVID-19 vaccination and Bell's Palsy, nor does any study examine risk tracking a formulation or component change over time for this outcome.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Formulation / component change incidence risk cohort OR self-controlled case series pubmed · 945 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no association OR null OR no increased risk Formulation / component change pubmed · 88286 hits · run 2026-09-07
does_not_resolve 38089855 · European heart journal open (2023) — Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
does_not_resolve 40440921 · Vaccine (2025) — Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
does_not_resolve 38875047 · The International journal of risk & safe (2024) — Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
ambiguous 36143376 · Life (Basel, Switzerland) (2022) — Safety of COVID-19 Vaccines: Spotlight on Neurological Complications.
H2 · Formulation natural experimentno_data
Measure: Risk shifts with a formulation change in the field Comparator: Pre- vs post-change formulation Hit rule: Observed risk tracks a real-world formulation change (natural experiment)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Formulation natural experiment intervention OR treatment OR reversal pubmed · 15142392 hits · run 2026-09-07
does_not_resolve 38189107 · Expert review of vaccines (2024) — Neoadjuvant personalized cancer vaccines: the final frontier?
H4 · Policy / pause signalno_data
Measure: Risk signal appears/disappears across a pause or policy change Comparator: Pre- vs post-pause period Hit rule: The signal appears or disappears coherently with a rollout / pause (H4)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Policy / pause signal intervention OR treatment OR reversal pubmed · 15142392 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Policy / pause signal no effect intervention pubmed · 0 hits (0 hits — negative) · run 2026-09-07
I3 · Infection coherenceno_data
Measure: Pattern is coherent with or distinct from infection Comparator: Infection-matched comparison Hit rule: The post-vaccine pattern is coherent with (or clearly distinct from) the infection pattern
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Infection coherence coherence OR latency OR susceptibility pubmed · 870068 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Infection coherence inconsistent OR contradicts pubmed · 27612 hits · run 2026-09-07
Mediator & biological gradient 24/24 evaluated
C1n · Dose strength gradientno_data
Measure: Risk vs dose strength (dose size) Comparator: Lower dose strength Hit rule: Monotonic dose-response in dose strength (larger dose -> higher risk)
Finding: The retrieved evidence does not provide any data on a monotonic dose-response gradient (larger dose → higher risk) for Bell's palsy after COVID-19 vaccination. The two systematic reviews (PMID 37272720, 36851114) examine incidence comparisons versus controls but do not analyze risk by dose strength. Case reports (PMID 35759681, 34336436) describe single events without dose-response analysis.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Dose strength gradient dose-response OR dose effect pubmed · 1299193 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no dose effect OR no dose-response Dose strength gradient pubmed · 152 hits · run 2026-09-07
7 retrieved record(s)
does_not_resolve 39082700 · The Journal of infectious diseases (2025) — Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
does_not_resolve 36090988 · Frontiers in immunology (2022) — A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
refutes_node 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
supports_node 36851114 · Vaccines (2023) — Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 34336436 · Cureus (2021) — Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
C2n · Dose number gradientno_data
Measure: Risk vs dose number (1st vs 2nd vs 3rd) Comparator: First dose Hit rule: Risk increases (or shows a defined pattern) with dose number
Finding: No retrieved evidence directly compares Bell's palsy risk across different dose numbers (1st vs 2nd vs 3rd) of COVID-19 vaccines. The available studies and case reports assess Bell's palsy after vaccination in general but do not analyze a dose-dependent gradient.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Dose number gradient dose-response OR dose effect pubmed · 1299193 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no dose effect OR no dose-response Dose number gradient pubmed · 596 hits · run 2026-09-07
7 retrieved record(s)
does_not_resolve 39082700 · The Journal of infectious diseases (2025) — Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
supports_node 36851114 · Vaccines (2023) — Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
supports_node 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 37344264 · Vaccine (2023) — Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink.
C3n · Measured-exposure tertilesno_data
Measure: Risk vs measured exposure tertile Comparator: Lowest-exposure tertile Hit rule: Risk ordered by measured-exposure tertile (high > mid > low)
Finding: No retrieved evidence directly measures risk of Bell's palsy ordered by measured-exposure tertiles of COVID-19 vaccine; the only relevant evidence consists of case reports and meta-analyses comparing vaccine groups to unvaccinated controls, not tertiles.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Measured-exposure tertiles dose-response OR dose effect pubmed · 1299193 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no dose effect OR no dose-response Measured-exposure tertiles pubmed · 41 hits · run 2026-09-07
7 retrieved record(s)
does_not_resolve 39082700 · The Journal of infectious diseases (2025) — Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
supports_node 36851114 · Vaccines (2023) — Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
ambiguous 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 34336436 · Cureus (2021) — Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
C4n · Organoid concentration curveno_data
Measure: Effect vs antigen concentration in organoid Comparator: Vehicle / zero antigen Hit rule: Dose-dependent effect across a graded concentration curve
Finding: The retrieved evidence includes systematic reviews and meta-analyses (PMID 37272720, PMID 36851114) that assess the incidence of Bell's palsy after COVID-19 vaccination, but none of the retrieved articles provide data on a dose-dependent effect of vaccine antigen concentration in an organoid model, which is the specific hit rule for this node.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Organoid concentration curve dose-response OR dose effect pubmed · 1299193 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no dose effect OR no dose-response Organoid concentration curve pubmed · 52 hits · run 2026-09-07
8 retrieved record(s)
does_not_resolve 39082700 · The Journal of infectious diseases (2025) — Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
does_not_resolve 36090988 · Frontiers in immunology (2022) — A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
supports_node 36851114 · Vaccines (2023) — Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
ambiguous 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
supports_node 34336436 · Cureus (2021) — Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine.
C5n · EC50 vs Cmax coherenceno_data
Measure: Measured exposure reaches effect threshold Comparator: Pharmacokinetic Cmax vs EC50 Hit rule: Achieved exposure (Cmax/tissue) plausibly reaches the in-vitro EC50
Finding: The retrieved evidence includes two systematic reviews and meta-analyses (PMID 37272720 and PMID 36851114) that assess the incidence of Bell's palsy after COVID-19 vaccination, but neither provides data on achieved Cmax/tissue exposure relative to in-vitro EC50. Two case reports (PMID 35759681 and PMID 35075436) describe Bell's palsy following vaccination but do not measure in-vivo exposure levels. No retrieved study addresses the pharmacokinetic/pharmacodynamic coherence of EC50 versus Cmax for this adverse event.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy EC50 vs Cmax coherence dose-response OR dose effect pubmed · 1299193 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy no dose effect OR no dose-response EC50 vs Cmax coherence pubmed · 41 hits · run 2026-09-07
6 retrieved record(s)
does_not_resolve 39082700 · The Journal of infectious diseases (2025) — Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis.
does_not_resolve 34477808 · JAMA (2021) — Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
refutes_node 37272720 · Otolaryngology--head and neck surgery : (2023) — Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.
supports_node 36851114 · Vaccines (2023) — Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
supports_node 35759681 · Revista medica del Instituto Mexicano de (2022) — [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].
ambiguous 35075436 · American journal of ophthalmology case r (2022) — Bell's palsy following COVID-19 vaccine administration in HIV+ patient.
E1 · Mediator identified in casesno_data
Measure: Mediator present in affected tissue/cells Comparator: Unaffected tissue / control Hit rule: The hypothesized mediator is detected in the affected compartment and not (or less) in control
Finding: No evidence found.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Mediator identified in cases in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Mediator identified in cases not associated mechanism pubmed · 1 hits · run 2026-09-07
1 retrieved record(s)
does_not_resolve 37716365 · The Lancet. Respiratory medicine (2023) — Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-bl
E2 · Mediator in healthy vaccineesno_data
Measure: Mediator detectable after vaccination Comparator: Pre-vaccination baseline Hit rule: Mediator appears after vaccination and tracks the exposure window
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Mediator in healthy vaccinees in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Mediator in healthy vaccinees not associated mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
E3 · Infection contrastno_data
Measure: Mediator absent/low after natural infection Comparator: Recovered natural infection Hit rule: Mediator signal is specific to vaccination vs a comparable natural-infection control
Finding: A single case report describes a 35-year-old female who developed left Bell's palsy 12 hours after receiving the first dose of mRNA-1273 vaccine, with no mention of a natural-infection comparator or assessment of mediator levels after natural infection.
supporting: COVID-19 vaccine Bell's Palsy mechanism Infection contrast in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Infection contrast not associated mechanism pubmed · 1 hits · run 2026-09-07
1 retrieved record(s)
supports_node 34763263 · Clinical imaging (2022) — Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report.
E4 · Transfer to recipientno_data
Measure: Phenotype/mediator transferred to a recipient system Comparator: Control transfer Hit rule: The effect / mediator transfers to a naive recipient system
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Transfer to recipient in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Transfer to recipient not associated mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
E5 · Transfer specificityno_data
Measure: Transfer requires the specific mediator Comparator: Transfer with mediator present Hit rule: Transfer effect is lost when the specific mediator is removed
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Transfer specificity in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Transfer specificity not associated mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
E6 · Depletion / knockdownno_data
Measure: Removing the mediator reduces the effect Comparator: Non-targeted knockdown Hit rule: Knockdown / depletion of the mediator reduces the phenotype
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Depletion / knockdown in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
Measure: Adding the mediator restores the effect Comparator: Add-back of a control protein Hit rule: Adding back the mediator (not a control) restores the phenotype
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Add-back rescue in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
Measure: Neutralizing the mediator blocks the effect Comparator: Isotype control Hit rule: Neutralization of the mediator (not an isotype control) blocks the phenotype
Finding: The retrieved evidence does not mention Bell's Palsy, mediator neutralization, or any experiment testing whether neutralizing a mediator blocks the phenotype of Bell's Palsy after COVID-19 vaccination.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Neutralization in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Neutralization not associated mechanism pubmed · 1 hits · run 2026-09-07
1 retrieved record(s)
supports_node 37731938 · EClinicalMedicine (2023) — Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial.
E9 · Isotype controlno_data
Measure: Isotype control does not reproduce the effect Comparator: Active antibody Hit rule: An isotype control fails to reproduce the block/activation
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Isotype control in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Isotype control not associated mechanism pubmed · 0 hits (0 hits — negative) · run 2026-09-07
F1 · Full product reproducesno_data
Measure: Full vaccine product reproduces the effect Comparator: No-product control Hit rule: The full product (not a subcomponent) reproduces the effect
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Full product reproduces component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Full product reproduces no effect component isolation pubmed · 0 hits (0 hits — negative) · run 2026-09-07
Measure: Vector/particle without antigen reproduces (or not) Comparator: Full product Hit rule: Effect attributed to (or excluded from) the vector/particle backbone alone
Finding: Retrieved evidence describes virus-vectored influenza vaccines, live bacterial vaccine vectors, measles vaccine, adenovirus-vectored universal influenza vaccines, viral vector-based therapeutic cancer vaccines, and viral vectors for malaria vaccine development, but none of the abstracts mention Bell's palsy, COVID-19 vaccines, or any adverse event related to empty vector/particle backbones.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Empty vector / particle component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
Measure: Irrelevant cargo does not reproduce the effect Comparator: Vector with the target antigen Hit rule: Irrelevant cargo fails to reproduce the effect (specificity)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Irrelevant cargo component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
Measure: Infection preparation vs product comparison Comparator: Product-derived preparation Hit rule: Effect compares correctly between infection and product preparations
Finding: No retrieved evidence addresses Bell's Palsy, COVID-19 vaccines, or any comparison of infection versus product preparations for Bell's Palsy. The retrieved evidence focuses on live bacterial and viral vector vaccine technologies and their applications, not on adverse events or safety comparisons.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Infection preparation component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
Measure: Cytokine/adjuvant mix alone reproduces (or not) Comparator: Individual components Hit rule: The effect is (or is not) reproducible by the cytokine/adjuvant mix alone
Finding: No evidence found that directly addresses whether a cytokine/adjuvant mix alone reproduces Bell's Palsy following COVID-19 vaccination.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Cytokine / adjuvant mix component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
Measure: Defined component combination reproduces the effect Comparator: Single components Hit rule: A defined combination reproduces the effect that single components do not
Finding: The retrieved evidence discusses virus-vectored influenza vaccines, live bacterial vaccine vectors, measles vaccine development, adenovirus-vectored universal influenza vaccines, viral vector-based cancer vaccines, and viral vectors for malaria vaccine development. None of these sources address COVID-19 vaccines, Bell's palsy, or component combination effects.
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Component combination component OR antigen OR vector pubmed · 2045311 hits · run 2026-09-07
Measure: Effect reproduced in 2D human cell culture Comparator: Untreated / control cells Hit rule: Effect reproduced in 2D primary human cells
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy 2D human cells animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy 2D human cells not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
G2 · Organoid / chipno_data
Measure: Effect reproduced in organoid / organ-on-chip Comparator: Unexposed organoid Hit rule: Effect reproduced in a 3D organoid / organ-on-chip system
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Organoid / chip animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Organoid / chip not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
H1 · Block in vitro / in vivono_data
Measure: Blocking the mediator/mechanism prevents the effect Comparator: Control intervention Hit rule: Blocking the mechanism prevents or reverses the effect (not with a control intervention)
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Block in vitro / in vivo intervention OR treatment OR reversal pubmed · 15142392 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Block in vitro / in vivo no effect intervention pubmed · 0 hits (0 hits — negative) · run 2026-09-07
Clinical / animal / host 7/7 evaluated
E10 · Host-line dependenceno_data
Measure: Effect depends on host line/cell type Comparator: Susceptible host line Hit rule: Effect is restricted to a defined host line / genotype, not universal
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy mechanism Host-line dependence in vitro OR patient-derived pubmed · 29244 hits · run 2026-09-07
Measure: Effect in animal via the clinical route of administration Comparator: Vehicle, same route Hit rule: Effect reproduced in an animal using the clinical route of administration
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Animal, clinical route animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Animal, clinical route not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
G4 · Susceptible animalno_data
Measure: Effect in a susceptible animal model Comparator: Non-susceptible model Hit rule: Effect in a defined susceptible animal model
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Susceptible animal animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Susceptible animal not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
G5 · Replication across labsno_data
Measure: Effect replicated in an independent lab Comparator: Original result Hit rule: The key effect is replicated in an independent laboratory
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Replication across labs animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Replication across labs not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
G6 · Blinded scoringno_data
Measure: Outcomes scored blinded Comparator: Unblinded reference Hit rule: Primary outcomes scored by a blinded assessor
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Blinded scoring animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Blinded scoring not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
G7 · Experimental time courseno_data
Measure: Effect follows a defined experimental time course Comparator: No-exposure time course Hit rule: The effect's onset/offset follows a defined experimental time course
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Experimental time course animal OR organoid OR cell model pubmed · 1818663 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Experimental time course not reproduced model pubmed · 0 hits (0 hits — negative) · run 2026-09-07
I4 · Susceptibility traitno_data
Measure: A host trait / marker defines susceptibility Comparator: Trait-negative hosts Hit rule: A defined host trait / marker enriches for susceptibility
Finding: no evidence found
Cited: (none)
supporting: COVID-19 vaccine Bell's Palsy Susceptibility trait coherence OR latency OR susceptibility pubmed · 870068 hits · run 2026-09-07
mirror: COVID-19 vaccine Bell's Palsy Susceptibility trait inconsistent OR contradicts pubmed · 27612 hits · run 2026-09-07
How this was built
Per node: a supporting and a mirror PubMed query built from the node's measure / population / comparator / hit_rule; top hits fetched (title + abstract); each record classified (supports / refutes / ambiguous) by xAI with a heuristic fallback; a per-node synthesis is generated strictly from the retrieved PMIDs; the node status is then rolled up to C1–C6. Full query provenance is shown per node above. Reproduce the build: python -m evidence_run. Data: data/evidence_run/state.json.